(Q37786770)

23 August 2017

1 reference

title

Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease (English)

1 reference

23 August 2017

1 reference

1 reference

Hamsten A

1

1 reference

23 August 2017

publication date

1 December 1990

1 reference

Bailliere's clinical endocrinology and metabolism

23 August 2017

published in

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

895-922

1 reference

Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Characterization of human high-density lipoproteins by gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasma triglyceride levels and coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Myocardial infarction in the familial forms of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

The triglyceride issue: a view from Framingham

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Effects of postprandial lipemia on plasma cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Low-density lipoproteins modified by lipid transfer protein have altered biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

A novel form of factor VII in plasma from men at risk for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

A new form of coagulation factor VII in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Factor VII-phospholipid complex in male survivors of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasma triglyceride determines structure-composition in low and high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Ischemic heart disease, atherosclerosis, and longevity.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Haemostatic function in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Severity of coronary atherosclerosis related to lipoprotein concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Defective fibrinolysis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Lipoproteins in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Overproduction of low density lipoproteins associated with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Haemostatic function and cardiovascular death: early results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Human low density lipoprotein structure: correlations with serum lipoprotein concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Slower removal of intestinal apolipoprotein B-48 than of apolipoprotein B-100 in severely hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein--postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Reappraisal of the role of insulin in hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasma insulin and lipoprotein concentrations: an atherogenic association?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Lipoprotein predictors of the severity of coronary artery disease in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Metabolic heterogeneity in very low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Haemostatic factors in human aortic intima

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Role of endothelium in sequestration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-intimas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Insulin and atheroma--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Effect of long chain triglyceride infusion on glucose metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980084-9

7 January 2021

10.1016/S0950-351X(05)80084-9

Identifiers

DOI

1 reference

23 August 2017

1 reference